NCT03497884 is a NA clinical trial of rTMS in Parkinson Disease, sponsored by Hangzhou Normal University.

Who is sponsoring NCT03497884?

NCT03497884 is sponsored by Hangzhou Normal University.

What drugs are being tested in NCT03497884?

Interventions in NCT03497884: rTMS.

What condition does NCT03497884 study?

NCT03497884 studies Parkinson Disease.

Is NCT03497884 still recruiting?

NCT03497884 is currently completed. Last updated 30 May 2018.

Last reviewed 2018-05-30 · How we verify

NCT03497884

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Individualized Precise Localization of rTMS on Primary Motor Area

Completed NA Last updated 30 May 2018

What this trial tests

NA trial testing rTMS in Parkinson Disease in 38 participants. Completed in 15 April 2018.

Timeline

4 September 2017

Primary endpoint
15 April 2018

15 April 2018

Quick facts

Lead sponsor	Hangzhou Normal University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	38
Start date	4 September 2017
Primary completion	15 April 2018
Estimated completion	15 April 2018
Sites	2 locations across China

Drugs / interventions tested

rTMS

Conditions studied

Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

Hangzhou Normal University

Who can join

Adults 19 to 30, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Parkinson's disease (PD) patients have some problem with self-initiated movement task. Compared with health controls, task meta-analysis found that PD patients showed abnormal activation in pre-supplementary motor area (pre-SMA) and putamen. And the functional connectivity has already been reported between pre-SMA and putamen in 2013. Repetitive Transcranial Magnetic Stimulation (rTMS) is a sage and painless technique to activate cortical areas. The deep brain structure can be activated via stimulating superficial cortex by rTMS. For investigating the mechanism of self-initiated movement, this project is using functional magnetic resonance imaging (fMRI) to individualize the precise localization in motor area and combining rTMS to activate putamen.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Low-frequency rTMS targeting individual self-initiated finger-tapping task activation modulates the amplitude of local neural activity in the putamen.
Wang J, Deng XP, Hu YS, Yue J, et al · · 2023 · cited 7× · PMID 36562546 · DOI 10.1002/hbm.26045

Verify or expand the search:

Other trials of rTMS

Trials testing the same drug.

NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD) · NA · not yet recruiting
NCT07580989 — Network Effects of Left M1 rTMS: A TMS-EEG Study · NA · recruiting
NCT07567053 — Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study · NA · not yet recruiting
NCT07451600 — Effectiveness of TMS on Spasticity and Balance for Patients With MS · NA · recruiting
NCT04532190 — Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder · NA · recruiting

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting

Other Hangzhou Normal University trials

Trials by the same sponsor.

NCT06536985 — Effect of an Oral Frailty Measures Intervention Programs in Institutionalized Elders · NA · not yet recruiting
NCT06519695 — Exercise Intervention for Pre-frail Elderly · NA · active not recruiting
NCT05496985 — Chinese Validation of the Simplified Evaluation of CONsciousness Disorders（SECONDs） · NA · completed
NCT06014476 — Psychological Symptoms and Burden in Caregivers of Patients With Disorders of Consciousness · completed
NCT06770348 — Investigating the Localization of Consciousness Through Patients with Disorders of Consciousness: Anterior Vs. Posterior · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03497884 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hangzhou Normal University
Last refreshed: 30 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03497884.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing